Richard JaiHwan Baek
CIK: 0002077868
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LIMN
Liminatus Pharma, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Baek Richard JaiHwan
Baek Richard JaiHwan (SEC CIK 0002077868) files insider reports with the SEC as Director of Liminatus Pharma, Inc. (LIMN).
Signal8 holds 1 ownership filing by Baek Richard JaiHwan, a Form 3, filed on Jul 21, 2025. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Baek Richard JaiHwan's filings is in LA PALMA, CA.
Other insiders filing for Liminatus Pharma, Inc. (LIMN)
- Valetudo Therapeutics LLC, 10% Owner
- Ewon Comfortech Co., Ltd., 10% Owner
- Iris Acquisition Holdings LLC, 10% Owner
- Lemons II Philip Wayne, Director
- KH Feelux Co., Ltd, 10% Owner
- Lee Eun Sook, Director